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Abstract 
Quality of life (QoL) characteristics are important in patients with diabetes mellitus (DM 1 and 2). 
Aim: Evaluate QoL and DM-associated factors among diabetic patients. Methods: Patients 
attending a University Hospital interviewed about sociodemographic, clinical and QoL 
characteristics, with QoL measured via the EQ-5D. Descriptive analysis, correlation, linear 
regression, univariate and multivariate analysis were performed. Results: 346 patients took part, 
comprising 67% women, 59% with DM2, and 32% DM1. DM 1 patients had a mean QoL of 
0.7369, with retinopathy, depression, dyslipidemia and a serious hypoglycemic crisis 
significantly reducing QoL. Patients with DM type 2 had mean QoL 0.6582, with hypertension, 
neuropathy, depression, cancer and dyslipidemia significantly reducing QoL. Reduced QoL also 
correlated with a lack of physical exercise. Males with both DM1 and 2 had a better QoL. 
Conclusion: Need for better disease monitoring and control combined with effective activities to 
improve self-FDUHUHGXFHFRPSOLFDWLRQVDQGLPSURYHSDWLHQWV¶4R/ 
 
Introduction 
 
Diabetes Mellitus (DM) is a chronic disease and is considered a public health problem across 
the world. Estimates from the International Diabetes Foundation (IDF) suggest that between 
2010 and 2030, there will be a 69% increase in numbers of adults with diabetes in developing 
countries and a 20% increase in developed countries [1]. By 2035, it is projected that nearly 600 
million people worldwide will have diabetes unless addressed, with almost 500 million at risk. 
Consequently, the population requiring either targeted prevention interventions or diabetes care, 
including the appropriate use of medicines, could soon exceed 1 billion [2,3,4]. 
 
This is relevant as diabetes is a principal cause of death worldwide [4,5], with considerable 
expenditure on the treatment of diabetes and its complications [1,3]. Diabetes also has a 
deleterious effect on patients¶clinical, social, and economic status as well as their quality of life 
(QoL) and survival [6,7]. Consequently, it is necessary to seek interventions that facilitate and 
promote self-care including treatment persistence to address this. It is recognised that a large 
number of variables including the type of diabetes (DM), use of insulin, age, race, social level, 
level of education, disease complications, psychological factors, knowledge about the disease, 
and type of health care may influence the QoL of patients with diabetes [8]. This has 
implications for future care. Younger age, living with someone, years of education, higher 
income and better glycemic control are all associated with better QoL [8]. Policies that promote 
self care should also enhance medication persistence, which can be a concern in these 
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patients. Cramer et al found that only 59% of patients with asymptomatic conditions such as 
hypertension, diabetes and hypercholesterolaemia took their medication for more than 80% of 
WKHLUGD\VµRQWKHUDS\¶LQD\HDU>@ 
 
This is important as good patient management will reduce the complications associated with 
diabetes, including microvascular and macrovascular complications [4,10-13]. Health education, 
a more active participation of the patient and the patient's family and the rapport between the 
patient and a multi professional health team are fundamental factors for the patient to acquire 
knowledge and adhere to their prescribed treatment [8]. Good quality medical care must be 
based around health care professionals, who have responsibility for SDWLHQWV¶quality of care so 
that they can create an enabling environment for instigating initiatives to improve patient care 
and reinforce the chances of success and their sustainability [14]. Self-management and 
decision-making should be major areas of focus to improve patient compliance and persistence, 
which is a concern in these patients.  
 
With respect to the Qol of patients with diabetes, Jacon et al [15] found that disease 
complications due to the lack of glycemic control impacted directly on their QoL. The authors 
also pointed out that the control of DM is not limited to the use of insulin and oral medications. It 
also requires for instant the patient's discipline to follow a diet and to practice physical exercise. 
Consequently, patient follow-up is of major importance. Soli et al [16] used the EQ-5D to 
evaluate how complications may affect QoL in patients with DM types 1 and 2 and also found 
higher utility values in patients without complications (0.90 and 0.85, respectively), in contrast to 
the values presented by DM patients with complications at 0.68 and 0.73, respectively. 
 
Consequently, studies evaluating of the impact of DM on the patients' QoL, especially in the 
clinic setting, may contribute with relevant information on ways to improve health care policies 
as well as initiatives to improve the follow-up and QoL of patients with DM. Accordingly, the aim 
of this study was to evaluate the epidemiologic profile and the factors associated with QoL in 
patients with DM types 1 and 2 treated at the Endocrinology Department of the University 
Hospital of the Federal University of Minas Gerais (HC-UFMG), which is a referral unit, within 
the Brazilian Public health system.  Additionally, ascertain the health-state utility (HSU) values 
of diabetic patients using the EQ-5D-3L based on direct and indirect measures of QoL. The 
HSU values will be useful for future cost-utility economic evaluations of potential future health 
care interventions in diabetic patients in Brazil. As a result, this study seeks to contribute 
relevant information for decision-making and health policy planning. 
 
Within the Brazilian Unified Health System (SUS, from the Portuguese, Sistema Único de 
Saúde), there is universal access and basic health interventions are carried out within primary 
and secondary health care institutions. DM2 patients are treated with diet, physical exercise 
and, if appropriate, oral antidiabetic medicines. Patients who do not obtain control of their 
diabetes are referred to the tertiary care level, referral center such as the Endocrinology 
Department of the University Hospital of the Federal University of Minas Gerais (HC-UFMG). In 
the most severe cases of the disease, i.e. patients without glycemic control affected by 
comorbidities or complications of diabetes, insulin is administered. 
 
Materials and methods 
 
In this cross-sectional study, the epidemiological profile and QoL-associated factors were 
assessed in patients with DM types 1 or 2. Patients who were at least 18 years old, had DM and 
attended consultations at the Endocrinology Service of University Hospital of the Federal 
University of Minas Gerais (HC/UFMG) were enrolled in the study. This is the typical place of 
care for patients with endocrinology and metabolic diseases in Minas Gerais State. In Brazil, the 
secondary care is undertaken referral centers for specialized diseases when patients need 
specific attention from medical specialists.  
 
Patients were invited to participate in the study from October 2013 to June 2014. All the 
participants were informed of the aims of the research and signed µTerms of Free Informed 
Consent¶IRUPV before answering a questionnaire which contained socioeconomic, 
demographic, clinical and QoL items. The interviews were performed by Pharmacy 
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undergraduate students from the Federal University of Minas Gerais after training in interview 
procedures, questionnaire application and QoL measurement. QoL was assessed with the 
EuroQol (EQ-5D-3L) version in Portuguese [17] answered by self-completion by responding 
patients. 
 
The generic instrument - EuroQol EQ-5D - was chosen for this study in view of its ease of 
application, the existence of a Portuguese translation validated to populations of both Minas 
Gerais State and Brazil as a whole, as well as its innovative use in DM patients from a referral 
health care center.  
 
This generic QoL questionnaire, which gives a single score that is necessary for obtaining 
measures of utility, is divided in two parts. The first part of the questionnaire is made up of a 
descriptive system with five health dimensions (mobility, self-care, usual activities, 
pain/discomfort and anxiety/depression). Each dimension has three levels of response (no 
problem, some or moderate problems and extreme problems). This part of the instrument allows 
the participant to describe the gravity of his or her health condition in each dimension. The 
combination of three different levels of responses for each of the five items gives 243 possible 
health conditions [18]. The EQ-5D was applied to a Brazilian population sample to define the 
utility values of each health condition [19]. The second part of the questionnaire contains a 
visual analogue scale (VAS) from 0 to 100 corresponding, respectively, to the worst and the 
best imaginable health condition [18]. 
 
The sociodemographic (gender, race, age, marital status, level of education, social class) and 
clinical (disease complications, comorbidities, other diseases) characteristics as well as aspects 
related to the treatment (number and type of medications used, time since diagnoses) make up 
the explanatory variables. Social class data were obtained according to the socioeconomic 
classification criteria of the Brazilian Association of Market Research Companies [20].  
 
Statistical analysis software SPSS version 22.0 was used for frequency and central tendency 
analysis of the data. Correlation and linear regression analyses were performed to evaluate 
differences between groups and for multiple comparisons. 
 
The correlation between the measured (VAS) and predicted (descriptive system) QoL of EQ-5D 
was evaluated with the Pearson correlation test. This test is a measure of the strength and 
direction of association that exists between two variables measured on at least an interval 
scale. 
 
Uni- and multivariate linear regression analyses were performed to verify the correlation 
between the predicted QoL (descriptive system) scores on EQ-5D and the explanatory 
variables. All variables statistically correlated to the result (S10) in the univariate analysis 
were included in the multivariate model. The variable deletion method, Backward Method, was 
used to obtain the final model. The initial and final models were compared using the 
verisimilitude rate test. The model adequacy was tested with residual analysis. Calculations 
ZHUHSHUIRUPHGDWFRQILGHQFHOHYHORIDQGVWDWLVWLFDOVLJQLILFDQFHRIS 
 
The pharmacotherapeutic follow-up of diabetes mellitus patients in Borges da Costa Infirmary of 
the Clinic Hospital of the Federal University of Minas Gerais (Project CAAE: 
21882813.7.0000.5149) was approved by the Clinical Research Ethics Committee of the 
Federal University of Minas Gerais. The Informed Consent Form was evaluated and approved 
for presentation in two copies. This was subsequently read to patients by the researcher, with 
the patients keeping a copy of the signed form. 
 
Results 
 
A total of 346 patients were interviewed from October 2013 to June 2014. Application of the full 
questionnaire lasted on average 20 minutes. Sampling was performed conveniently following 
the consultation/treatment schedule at the reference health care center. The sample size 
corresponded to 45% of the total number of DM patients treated at the clinics in the study 
period. The sex and DM type profiles of the sample were similar to those of the referral health 
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care center generally. Only 15% of the patients refused participation in the study, 73% of whom 
were from the metropolitan region or the countryside and 26% were male, which was similar to 
the profile of the participants. Among the reasons given for lack of participation were lack of 
interest (47%), lack of time (33%) and mobility difficulties (12%).  
 
Some of the descriptive analysis results including clinical characteristics are presented in 
Tables 1 and 2.  
 
233 of the participants were female (67%) and 242 were not white (71%), comprising black, 
brown, yellow and indigenous groups. 32% (112) of the participants had DM type 1 and 59% 
(205) had DM type 2. The remainder reported they did know whether they had DM 1 or 2 and 
1% reported not to have DM (Table 1).  
 
The average age of patients with DM type 1 was 37.53 years (SD = 12.29), median 38 years 
(range: 18 to 78). 83% were between 18 and 49 years, with most patients from social class C 
(57%), followed by classes A and B (37%) and D and E (6%). The majority of patients were 
single (45%), followed by married (32%), divorced (10%), separated (4%), cohabited (4%) and 
widowed participants (3%). 66% had studied for at least eight years. Most of the participants 
lived in Belo Horizonte (48%) or in the metropolitan region (36%). A significant number treated 
(16%) lived in the countryside. The average time since DM diagnosis was 18.20 years (SD = 
9,69), median 18.50 years (range: 1 to 44). All of the participants took DM-specific medication, 
86% of whom took insulin or analogues and 14% took oral antidiabetic medication. The average 
number of medicines used by patients was 4.75 (SD = 2,968), median 4 (range 1 to 14). 57% of 
the DM patients were hypertensive and 76% were obese. Dyslipidemia was observed in 65 
(59%), who typically took simvastatin. Hypoglycemia in the previous 30 days was reported by 
64%. Hospitalization in the previous six months was reported by 18%, 8% of which were related 
to DM. 40% reported not having undertook physical exercise in the previous 30 days and 65% 
reported adherence to a DM-specific diet. 
 
The average age of patients with DM2 was 55.51 years (SD = 12.29), median 56 years (24 to 
84). 88% were between 40 and 79 years, with most patients from social class C (61%), followed 
by classes A and B (28%) and D and E (11%). Most patients were married (51%), followed by 
single (22%), widowed (14%), divorced (5%), separated (5%) and cohabited (3%). 66% of 
patients had studied for less than eight years. Most lived in Belo Horizonte (46%) or in the 
metropolitan region (40%), with 14% living in the countryside. The average time since DM 
diagnosis was 12.30 years (SD = 9.57), median 10 years (range: 0 to 47). All patients took DM-
specific medication, 70% of whom took insulin or analogues combined with oral antidiabetic 
medication and 39% had monotherapy. The average number of medicines was 5.92 (SD = 
2,876), median 6 (range 1 to 14). 77% were hypertensive and 57% were obese. Dyslipidemia 
was seen in 132 (64%), who typically took simvastatin. Hypoglycemia in the previous 30 days 
was reported by 30%, 21% of whom needed help, which means that they presented a severe 
hypoglycemic event. Hospitalization in the previous six months was reported by 22%, 6% of 
which were related to DM. 42% reported not having undertook physical exercise in the previous 
30 days and 71% reported adherence to a DM-specific diet. 
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Table 1. Socioeconomic, demographic characteristics and type of diabetes mellitus among the 
patients treated at the endocrinology referral health care center in Belo Horizonte from October 
2013 to June 2014 
 
Characteristics Diabetes 
Type 1 
Diabetes 
Type 2 
Total**** 
 N % N % N % 
Sex 
Male 37 33 64 31 113 33 
Female 75 67 141 69 233 67 
 Total 112 100 205 100 346 100 
Race 
White 38 34 54 27 100 29 
Non-white* 73 66 149 73 242 71 
 Total 111 100 203 100 342 100 
Marital 
Status** 
With a 
partner 
Married 35 32 101 51 149 44 
Cohabiting 7 6 7 3 15 5 
Without 
a 
partner 
Single 49 45 44 22 102 30 
Separated 4 4 10 5 14 4 
Divorced 11 10 10 5 25 7 
Widowed 3 3 28 14 33 10 
  Total 109 100 200 100 338 100 
Level of education 
At least 8 years of 
education 
74 66 69 34 237 68 
Less than 8 years of 
education 
38 34 134 66 107 32 
 Total 112 100 203 100 344 100 
Economic class*** 
A and B 41 37 58 28 218 63 
C 64 57 124 61 122 35 
D and E 7 6 22 11 6 2 
 Total 112 100 204 100 346 100 
Place of residence 
Belo Horizonte 53 48 92 46 153 45 
Metropolitan region 39 36 81 40 130 38 
Outside the 
metropolitan region 
18 16 29 14 56 17 
 Total 110 100 202 100 339 100 
NB: * Category Non-white comprises black, brown, yellow and native Brazilian; ** Marital status 
"Others" corresponded to 1%; *** A = best economic conditions and F the worst economic 
condition according to ABEP, 2014 (F not seen in this study). **** Total of number the patients 
interviewed included those who did not know if they had DM and those who say they do not 
have DM. 
 
Table 2 includes the clinical characteristics of the patients, again broken down into DM1 and 
DM2. 
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Table 2. Clinical characteristics of the diabetes mellitus patients treated at the endocrinology 
referral health care center in Belo Horizonte from October 2013 to June 2014. 
 
Characteristics 
Diabetes 
Type 1 
Diabetes 
Type 2 
Total** 
N % N % N % 
Type of DM 
medication 
Insulin and/or 
analogs 
96 86 44 21 151 44 
Insulin and/or 
analogs + oral AD 
16 14 81 49 99 29 
Only oral AD 0 0 80 39 91 26 
Does not take any 
medication 
0 0 0 0 5 1 
 Total 112 100 205 100 346 100 
Hypertension* 
Yes 63 57 157 77 220 64 
Not 48 43 48 23 125 36 
 Total 112 100 205 100 345 100 
Overweight* Yes 85 76 116 57 158 46 
Not 27 24 86 43 185 54 
 Total 112 100 202 100 343 100 
Retinopathy* 
Yes 64 57 64 32 122 36 
Not 48 43 138 68 221 64 
 Total 112 100 202 100 343 100 
Diabetic foot* Yes 104 93 28 14 85 11 
Not 08 7 174 86 254 89 
 Total 112 100 202 100 339 100 
Diabetic 
nephropathy* 
Yes 75 68 46 23 145 25 
Not 36 32 155 77 193 75 
 Total 111 100 201 100 338 100 
Diabetic 
neuropathy* 
Yes 72 67 95 47 135 43 
Not 36 33 107 53 209 57 
 Total 108 100 202 100 344 100 
Depression* 
Yes 71 64 81 40 25 39 
Not 40 36 123 60 320 61 
 Total 111 100 204 100 345 100 
Blindness* Yes 105 94 16 8 194 7 
Not 7 6 189 92 149 93 
 Total 112 100 205 100 343 100 
Dyslipidemia* 
Yes 65 59 132 64 93 57 
Not 45 41 73 36 248 43 
 Total 110 100 205 100 341 100 
Hypoglycemi
c crisis 
Not 40 36 143 70 202 59 
Light 25 23 19 9 46 14 
Serious 45 41 43 21 93 27 
 Total 110 100 205 100 341 100 
Hospitalizatio
n in the 
previous 6 
months 
Not happened 92 82 158 78 273 81 
Happened but not has 
relation with diabetes 
11 10 32 16 
45 13 
Happened and has 
relation with diabetes 
9 8 12 6 
21 6 
 Total 112 100 202 100 339 100 
Do physical 
exercise 
Yes 67 60 116 58 164 48 
Not 44 40 83 42 180 52 
 Total 111 100 199 100 344 100 
NB: DM ± diabetes mellitus, AD ± antidiabetic. * Diagnosis of. **Total of number the patients 
interviewed, included those who don¶t know if they have DM and those who say they do not 
have DM. 
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Analysis of the EQ-5D descriptive system in patients with DM1 (Table 3) showed that 22% of 
patients had a perfect health condition (11111), followed by 11122 and 11121 (13%) and 11112 
(11%); other health conditions appeared in smaller proportions and the worst health condition 
(33333) was not seen. Moderate problems impacting on QoL related to the dimensions of 
pain/discomfort (50%), anxiety/depression (40%), mobility (23%) and usual activities (22%). The 
self-care dimension affected the smallest number of patients (8%). The QoL measure calculated 
based on the preferences of the general Brazilian population with the EQ-5D descriptive system 
showed a moderate correlation (0.240; p=0.011) with the VAS direct measure. The mean VAS 
was 72.14 (SD = 21.021) and median 80 (range: 0 to 100). Utility values obtained for this 
Brazilian population ranged from 0.164 to 1.0, with a mean utility of 0.73687 (SD = 0.1900) and 
median of 0.7370. After stratification of the indirect QoL measures for the sex of patients, we 
found 0.7905 and 0.7104 for males and females, respectively, with a significant difference at 
95% confidence level (p=0.035). 
 
Analysis of the EQ-5D descriptive system in patients with DM2 (Table 3) showed that 14% of 
patients had perfect health condition (11111), followed by 11122 (12%), 11121 (8%), 11112 
(6%), 21222 (6%), 21121 (5%) and 21122 (5%); other health conditions appeared in smaller 
proportions and the worst health condition (33333) was again not seen. Moderate problems 
impacting on QoL related to the dimensions of pain/discomfort (56%), anxiety/depression 
(47%), mobility (45%) and usual activities (33%). The self-care dimension affected the smallest 
number of participants (10%). The QoL measure calculated based on the preferences of the 
general Brazilian population with the EQ-5D descriptive system showed a moderate correlation 
(0.431; p=0.000) with the VAS direct measure. The mean VAS was 68 (SD = 18.990) and 
median 70 (range: 0 to 100). Utility values for this Brazilian population ranged from 0.137 to 1.0, 
with a mean utility of 0.65817 (SD = 0.2020) and median of 0.6670. After stratification of the 
indirect QoL measures for the sex of patients, we found 0.71013 and 0.63459 for males and 
females, respectively, with a significant difference at 95% confidence level (p=0.013). 
 
Table 3. EQ-5D scores of patients with diabetes mellitus treated at the endocrinology referral 
health care center in Belo Horizonte from October 2013 to June 2014. 
 
QoL Scores N Mean Standard Deviation 
Indirect QoLa ± Diabetes T1* 
Indirect QoLa ± Diabetes T2** 
112 
205 
0,73687 
0.65817 
0,1900 
0.2020 
     
           Diabetes T1* Diabetes T2** 
EQ-5D 
Dimensions*** 
  N %  N     % 
Mobility 
1 85 76 1 111 54 
2 26 23 2 92 45 
3 1 1 3 2 1 
Self-care 
1 103 92 1 183 89 
2 9 8 2 20 10 
3 0 0 3 2 1 
Usual activities 
1 86 77 1 131 64 
2 25 22 2 67 33 
3 1 1 3 7 3 
Pain or discomfort  
1 46 41 1 52 25 
2 56 50 2 114 56 
3 10 9 3 39 19 
Anxiety or depression 
1 47 42 1 77 38 
2 45 40 2 97 47 
3 20 18 3 31 15 
NB: * Diabetes mellitus Type 1; ** Diabetes mellitus Type 2; *** 1 = no problem, 2 = moderate 
problems, 3 = extreme problems; a Calculated using the EQ-5D five dimensions; QoL ± quality 
of life. 
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When stratifying the analysis by gender, males had significantly (p = 0.035) higher mean Qol 
(0.79046 ± 0.1751) than females (0.71043 ± 0.19259). The same was seen for mean VAS 
values (p = 0.000), with males at 81.97 ± 14.082 and females at 67.23 ± 22.24. In stratified 
analysis by gender and age, these values were higher for men, but no significant difference 
between age groups (p>0.05). 
 
ANOVA and multivariate correlation analyses indicated 20 significant explanatory variables 
(p<0.10) for the indirect QoL measure. After the sequential deletion of non-significant variables, 
the final model for the EQ-5D descriptive model for DM1 and 2 are presented in Table 4. The 
model for DM 1 showed that retinopathy, depression, dyslipidemia diagnosed and serious 
hypoglycemic crisis significantly reduced QoL (p<0.05). The model for DM2 showed that 
hypertension, neuropathy, depression, cancer and dyslipidemia significantly reduced SWLHQWV¶
QoL (p<0.05). A reduction in QoL also correlated with lack of physical exercise (p=0.009).  
 
Table 4: Regression analysis of factors associated with quality of life measured with EQ-5D and 
patients with diabetes mellitus types 1 and 2 treated at the endocrinology referral health care 
center in Minas Gerais, Brazil, from October 2013 to June 2014. 
 
Variables EQ-5D 
Diabetes mellitus type 1 
Fixed part Coefficient 
Standard 
Deviation 
p value 
Constant 0,885 0,030 0,000 
Retinopathy (yes) -0,068 0,034 0,048 
Depression (yes) -0,124 0,035 0,001 
Dyslipidemia (yes) -0,075 0,034 0,027 
Hypoglycemic crisis (serious) -0,038 0,019 0,043 
Diabetes mellitus type 2 
Fixed part Coefficient 
Standard 
Deviation 
p value 
Constant 0,899 0,032 0,000 
Hypertension (yes) -0,072 0,029 0,015 
Neuropathy (yes) -0,122 0,025 0,000 
Depression (yes) -0,089 0,026 0,001 
Cancer (yes) -0,108 0,035 0,002 
Dyslipidemia (yes) -0,061 0,027 0,023 
Physical Exercise (none) -0,066 0,025 0,009 
 
Discussion 
 
The prevailing sociodemographic characteristics: female, not white, classes B and C, living with 
someone, in Belo Horizonte or the metropolitan region, average age of 49 years, mean time of 
diagnosis of 14 years are very similar to DM patient data obtained with another generic 
questionnaire reported by Alves et al [21]. Ferreira and Santos [22] evaluated the negative 
impact of DM on the life of patients and also observed a predominance of females (71%), but an 
average age of 57 years (SD = 10.9). 
 
Preventive health habits and care are more familiar to females, which may be associated with 
the greater frequency of female consultations at this referral health care center. Gomes et al 
[23] reported that males rarely seek health care due to a predominant model of masculinity. 
Male characteristics such as invincibility, strength and virility are incompatible with 
demonstrations of weakness, fear, anxiety and diffidence shown in the search for health care 
services. Consequently, according to these authors, males are bound by cultural ties that make 
the adoption of self-care practices more difficult. Furthermore, Alves et al [24] observed that 
males seek out health care services only in extreme conditions and attributed their low demand 
to males' being more complacent, irresponsible, living for work, being home supporters, in 
addition to personal aspects linked to lack of knowledge. However, the Brazilian workforce data 
do not corroborate the argument that males do not seek health care because they are home 
providers, as the head of many households at present are females. The greatest QoL value 
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observed between males in this study may be explained by the fact that males enjoy better 
health conditions. 
 
The mean QoL value obtained by indirect measurement with the EQ-5D (0.6878 ± 0.0109) 
corresponds to the mean values of the valuation parameters (- 0.235 to 0.869) found by 
Andrade et al [25] in the general population of Minas Gerais, which had 5% DM patients. Males 
presented lower minimum values than females and a greater standard deviation. However, 
males also apparently had higher QoL than females, which was also reported by Alves et al 
[21], as well as in our study. 
 
The QoL measure calculated indirectly, based on the preferences of the general Brazilian 
population with the EQ-5D descriptive system, had a correlation 0.410 (for patients DM2; 
p=0.000) and 0.240 (for patients DM1; p=0.011) with the VAS direct measure of QoL. Alvares et 
al [26] found a similar value (0.386) using the same questionnaire in renal replacement therapy 
patients and Sakamaki et al [27] found correlation of 0.331 using EQ5D in patients with type 2 
diabetes mellitus in Japan. 
 
The present results show that a diagnosis of hypertension, neuropathy, depression, cancer, 
dyslipidemia and lack of physical exercises were significantly related to a low QoL for patients 
with DM2. For DM1 patients, retinopathy, depression, dislipidemia and serious hypoglycemic 
crisis decreased their QoL (Table 3). This is similar to the findings of Aguiar et al [8]. As 
mentioned, these authors found evidence that DM type, use of insulin, age and patient race, 
social and education levels, disease complications, psychological factors, knowledge about the 
disease, type of care and other factors may influence the QoL of DM patients. Our findings are 
also similar to Soli et al [16], who using the EQ-5D to evaluate how complications may affect 
QoL in patients with DM types 1 and 2. They found higher utility values in patients without 
complications (0.90 and 0.85, respectively) versus those with complications, 0.68 and 0.73, 
respectively. Zhang et al. [28] found a similar mean utility value (0.80) in DM patients using the 
EQ-5D. 
 
Similarly to Alves et al [21], we also did not find any correlation between QoL and age, marital 
status and number of years with DM. 
 
Regarding the type of DM medication used, Fal et al [29] reported that patients treated with 
insulin seemed to have a more stable QoL, to be less susceptible to DM-related factors such as 
comorbidities, overweight, and others, when compared to patients who used oral hypoglycemic 
medication. However, no association was found in this study between the type of medication 
used and QoL. 
 
Regarding risk factors associated with DM, arterial hypertension, obesity and dyslipidemia 
predominated, which is in agreement with other studies [30-34]. Consequently, there needs to 
EHDFWLYHPDQDJHPHQWRISDWLHQWV¶EORRGDQGOLSLGOHYHOVWKHODWWHUIRULQVWDQFHZLWKPJ
simvastatin [10,13]. 
 
A recent systematic review indicated that depression is negatively associated with QoL in 
patients with DM type 2. Despite a number of factors negatively related with DM, including long 
term treatment complications and comorbidities with a negative effect on QoL, new research 
has also proposed a contribution from this psychological factor [35]. Our study supports this 
finding. 
 
A positive correlation between physical exercise and health-related QoL has also been 
observed in a study with another generic QoL questionnaire [21]. Similar to our study, lack of 
physical exercise was associated with a negative effect on QoL. Additional studies should be 
undertaken to further elucidate this association to provide future guidance. 
 
In our study, the greatest losses of information were detected for questions on the type of DM 
(9%) and "if (the participant) has ever had or presently has HIV/AIDs" (11%), which may be 
attributed to prejudice about both diseases. Specifically in the case of DM, lack of knowledge 
(8% reported not to know whether they had DM) and disease denial (1%) were seen in this 
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study as well as in other studies [36]. There were also many losses regarding current medicines 
being taken by patients because not everyone interviewed had their prescription with them or 
remembered all the medicines they were currently prescribed. Consequently, this variable 
ZDVQ¶WXVHGLQWKLV model. 
 
A greater frequency observed regarding the adoption of a DM-specific diet can be partially 
related to a social desirability bias. Consequently, we believe patients may have answered the 
questionnaire according to a socially recommend health style that does not correspond to his or 
her daily habits.  
 
The EuroQol group recently introduced a new version of the instrument with 5 levels (EQ-5D-
5L); however, it has not yet been validated for the Brazilian population. Some countries have 
already started its evaluation, e.g. Golicki et al [37], and it is likely we will use the updated 
versions in future studies once validated. 
 
One of the major limitations of this study is that it is cross sectional, and, therefore, does not 
allow the establishment of a temporal correlation in the determination of causal associations. It 
also presents information bias, since the data was collected with a questionnaire and the QoL 
evaluation was done with a generic instrument. Regarding EQ5D, is known that a ceiling effect 
may occur when a great number of the reported health condition values are high, because face-
to-face interviews may enhance the risk of social desirable answers. Patients also reported they 
had difficulty understanding VAS scores. This may have occurred because of the high level of 
functional illiteracy (27%) or the unsatisfactory educational level in Brazil [38]. 
 
We acknowledge this study does not have external validity as the studied population is specific 
and treated at a university referral health care center located in Belo Horizonte. In addition, 
although patients from Belo Horizonte, the metropolitan region and from the countryside are 
treated at this center, the population is not representative of the State as a whole. Despite this, 
internal validity was good and demonstrated by the validation of the questionnaire through its 
high-quality data reliability and reproducibility for 13% of the sample. In addition, this study was 
conducted among a diverse multicultural and socio-economic population adding to the literature 
LQWKLVILHOGDQGDGGVWRNQRZOHGJHDERXWWKHLPSDFWRI'0RQSDWLHQWV¶XWLOLW\KHOSLQJZLWK
future economic evaluations among the Brazilian population.  
 
The originality of this study is in the evaluation of QoL in DM patients treated in routine clinical 
care at a referral health care center run by a well-qualified team. The study presents the 
epidemiological profile and quality of life of these patients, contributing to early evaluations of 
interventions to improve their quality of life. The results show that most of the DM patients 
present with a large number of associated comorbidities and low QoL scores. These data can 
be useful in future economic evaluations evaluating different treatment approaches, including 
new interventions, among SUS patients with DM. Ensuring access to ambulatory and hospital 
care as well as access to medicines is essential in managing this chronic disease, but may not 
be sufficient to appreciably improve their health condition. Specific studies on the quality of the 
use of medicines and their impact on utility and cost-utility, e.g. cost per quality adjusted life 
years, should be performed in the real world in order to better understanding DM as a health 
condition and its optimal management. This will be the subject of future research with our 
patients. 
 
Key messages: 
 
x The incidence and prevalence of diabetes is increasing and represents a major world-wide 
health problem in terms of its morbidity and associated QHJDWLYHLPSDFWRQSDWLHQWV¶quality-
of-life, mortality and associated costs  
x However, the treatment of patients with diabetes, bringing the patient's metabolic state as 
close as possible to the normal physiology, is not easily achieved. As s result, requiring the 
patient's and the family's understanding and efforts to address this 
x Consequently, evaluating the epidemiologic profile and the factors associated with QoL in 
patients with diabetes could contribute to the design of interventions aiming at effective self-
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care, promotion of the quality of use of medicines and improved individual and collective 
health conditions 
x The mean QoL of patients with Type 1 and 2 DM attending the Endocrinology Department 
of the University Hospital of the Federal University of Minas Gerais (HC-UFMG) was 0.6878 
(SD = 0.0109) using the EuroQol questionnaire (EQ-5D). The mean QoL was lower in DM2 
patients 
x Multivariate analysis showed that having a diagnosis of neuropathy, depression, cancer, 
blindness and dyslipidemia significantly (p<0.05) decreased QoL 
x Multiple medications (p<=0.001) and the lack of physical activity (p=0.028) also decreased 
SDWLHQWV¶QoL. Male gender was associated with better QoL (p=0.016) 
x The findings indicate a need to further implement educational measures regarding health 
conditions, the importance of the treatment and its persistence, as well as the need of 
effective self-care as early as possible to reduce complications and improve the QoL of 
patients. 
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